These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30539844)

  • 1. A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy.
    Wang Q; Qi F; Song X; Di J; Zhang L; Zhou Y; Lu X; Chang J; Yu Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1048-S1051. PubMed ID: 30539844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
    Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
    Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
    Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
    Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
    Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma.
    Patel S; DiBiase S; Meisenberg B; Flannery T; Patel A; Dhople A; Cheston S; Amin P
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):739-42. PubMed ID: 21353747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.
    Prabhu RS; Won M; Shaw EG; Hu C; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP
    J Clin Oncol; 2014 Feb; 32(6):535-41. PubMed ID: 24419119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
    Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
    Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
    McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
    Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
    van den Bent MJ; Klein M; Smits M; Reijneveld JC; French PJ; Clement P; de Vos FYF; Wick A; Mulholland PJ; Taphoorn MJB; Lewis J; Weller M; Chinot OL; Kros JM; de Heer I; Verschuere T; Coens C; Golfinopoulos V; Gorlia T; Idbaih A
    Lancet Oncol; 2018 Sep; 19(9):1170-1179. PubMed ID: 30115593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
    Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
    Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
    Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
    Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma.
    Taylor BV; Buckner JC; Cascino TL; O'Fallon JR; Schaefer PL; Dinapoli RP; Schomberg P
    J Clin Oncol; 1998 Jun; 16(6):2195-201. PubMed ID: 9626221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "A prospective study of assessment of neurocognitive function in illiterate patients with gliomas treated with chemoradiation": Assessment of neurocognitive function in gliomas.
    Valiyaveettil D; G A; Malik M; Eaga P; Ahmed SF; Joseph D
    Cancer Treat Res Commun; 2021; 26():100288. PubMed ID: 33352469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
    Froklage FE; Oosterbaan LJ; Sizoo EM; de Groot M; Bosma I; Sanchez E; Douw L; Heimans JJ; Reijneveld JC; Lagerwaard FJ; Buter J; Uitdehaag BM; Klein M; Postma TJ
    J Neurooncol; 2014 Jan; 116(2):387-94. PubMed ID: 24264531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
    Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
    J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.
    Peters KB; West MJ; Hornsby WE; Waner E; Coan AD; McSherry F; Herndon JE; Friedman HS; Desjardins A; Jones LW
    J Neurooncol; 2014 Dec; 120(3):499-506. PubMed ID: 25115739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.
    Stöckelmaier L; Renovanz M; König J; Nickel K; Hickmann AK; Mayer-Steinacker R; Nadji-Ohl M; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
    World Neurosurg; 2017 Jun; 102():383-399. PubMed ID: 28288921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Malignant Transformation of Low-Grade Glioma.
    Murphy ES; Leyrer CM; Parsons M; Suh JH; Chao ST; Yu JS; Kotecha R; Jia X; Peereboom DM; Prayson RA; Stevens GHJ; Barnett GH; Vogelbaum MA; Ahluwalia MS
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):965-971. PubMed ID: 29485076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.